Slingshot members are tracking this event:
European Commission Expected to Make Final Decision in ~60 Days on Gilead's (GILD) Vemlidy in Adults with Chronic HBV Infection
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jan 11, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords European Comission, Chmp, Vemlidy, Chronic Hepatits B Virus Infection, Hbv, Tenofovir Alafenamide